Perioperative beta-blockade, 2008: What does POISE tell us, and was our earlier caution justified?

British Journal of Anaesthesia

Volumn 101, Issue 2, 2008, Pages 135-138

  Sear, J W ^a   Giles, J W ^a   Howard Alpe, G ^a   Foex P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; METOPROLOL; METOPROLOL SUCCINATE; PLACEBO;

ACUTE HEART INFARCTION; ANGINA PECTORIS; BETA ADRENERGIC RECEPTOR BLOCKING; BRADYCARDIA; CLINICAL PRACTICE; CORONARY RISK; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; ECHOCARDIOGRAPHY; EDITORIAL; ELECTIVE SURGERY; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; INTUBATION; ISCHEMIC HEART DISEASE; LARYNGOSCOPY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; STROKE; SURGICAL PATIENT; SURGICAL STRESS; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR SURGERY;

EID: 47249085534     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen194     Document Type: Editorial

References (36)

1. Viljoen JF, Estafanous FG, Kellner GA. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg 1972; 64: 826-30
2. Prys-Roberts C, Foëx P, Biro GP, Roberts JG. Studies of anaesthesia in relation to hypertension. V. Adrenergic beta-receptor blockade. Br J Anaesth 1973; 45: 671-81
3. Stone JG, Foëx P, Sear JW, et al. Risk of myocardial ischaemia during anaesthesia in treated and untreated hypertensive patients. Br J Anaesth 1988; 61: 675-9
4. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88: 7-17
5. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335: 1713-20
6. Devereaux PJ, Yusuf S, Yang H, Choi PT-L, Guyatt GH. Are the recommendations to use perioperative β-blocker therapy in patients undergoing noncardiac surgery based on reliable evidence? Can Med Assoc J 2004; 171: 245-7
7. Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997; 127: 313-28
8. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341: 1789-94
9. Howell SJ, Sear JW, Foëx P. Peri-operative β-blockade: a useful treatment that should be greeted with cautious enthusiasm. Br J Anaesth 2001; 86: 161-4
10. Eagle K-A, Berger P-B, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary. J Am Coll Cardiol 2002; 39: 542-53
11. Urban MK, Markowitz SM, Gordon MA, et al. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 2000; 90: 1257-61
12. Zaugg M, Tagliente T, Lucchinetti E, et al. Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 1999; 91: 1674-86
13. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. J Am Med Assoc 2002; 287: 1435-44
14. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003; 97: 623-33
15. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. Br Med J 2005; 331: 313-21
16. Wiesbauer F, Schlager O, Domanovits H, et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg 2007; 104: 27-41
17. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative betablocker therapy. Circulation 2006; 113: 2662-74
18. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary. Circulation 2007; 116: 1971-96
19. Opie LH. Beta-blockade should not be among several choices for initial therapy of hypertension. J Hypertens 2008; 26: 161-3
20. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366: 1622-32
21. Devereaux PJ, Yang H, Guyatt GH, et al. Rationale, design, and organization of the Perioperative Ischemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 2006; 152: 223-30
22. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-47
23. Kopecky SL. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction. Am J Cardiol 2006; 98: 1115-9
24. Jenkins NP, Keevil BG, Hutchinson IV, Brooks NH. Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease. Am J Med 2002; 112: 269-74
25. Dandona P, Ghanim H, Brooks DP. Antioxidant activity of carvedilol in cardiovascular disease. J Hypertens 2007; 25: 731-41
26. Rinfert S, Abrahamowicz M, Tu J, et al. A population-based analysis of the class effect of β-blockers after myocardial infarction. Am Heart J 2007; 153: 224-30
27. BNF55: British National Formulary March 2008. London: BMJ Publishing Group Ltd and RPS Publishing Group, 2008
28. Fleisher L, Poldermans D. Perioperative β blockade: where do we go from here? Lancet 2008; 371: 1813-4
29. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999; 88: 477-82
30. Beattie WS, Wijeysundera DN, Karkouti K, et al. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth Analg 2008; 106: 1039-48
31. Biccard BM, Sear JW, Foëx P. Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes. Br J Anaesth 2008; 100: 23-8
32. Zaugg M, Bestmann L, Wacker J, et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology 2007; 107: 33-44
33. Fleisher LA. Perioperative beta-blockade: how best to translate evidence into practice. Anesth Analg 2007; 104: 1-3
34. Giles JW, Sear JW, Foëx P. Effect of chronic beta-blockade on peri-operative outcome in patients undergoing non-cardiac surgery: an analysis of observational and case control studies. Anaesthesia 2004; 59: 574-83
35. Shammash JB, Trost JC, Gold JM, Berlin JA, Golden MA, Kimmel SE. Perioperative beta-blocker withdrawal and mortality in vascular surgical patients. Am Heart J 2001; 141: 148-53
36. Wiysonge CS, Bradley H, Mayosi BM, et al. Beta-blockers for hypertension. Cochrane Database Syst Rev 2007: CD002003